Quantum Cyber completes $6M takeover: David Lazar gains 95% control, board overhauled

Filed April 28, 2026 · Period ending April 22, 2026 · ~1 min read

Key Changes

• high

  David Lazar acquired over 95% voting control through $6M private placement completed in two closings (Feb 17 and Apr 22, 2026), with preferred shares convertible into 477M ordinary shares—representing extreme dilution to existing shareholders.

  Item 1.01, Item 5.02 verify on EDGAR →
• high

  Complete board overhaul: 4 directors resigned (including Co-CEO Guido Baechler) and 2 new directors appointed on April 22, leaving a 4-member board with 3 independent directors and new controlling shareholder Lazar.

  Item 5.02 verify on EDGAR →
• high

  Company changed name from Mainz Biomed N.V. to Quantum Cyber N.V., signaling fundamental business pivot from biomedical to cyber/technology sector.

  Item 5.03 verify on EDGAR →